KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy

Non-small-cell lung cancer, histologically classified into adenocarcinoma (AD) and squamous cell carcinoma, is one of the most deadly malignancies worldwide. Lung AD (LUAD) could benefit of a plethora of target therapies and, in the last few years, also of immunotherapies. Here we focused on a real-...

Full description

Bibliographic Details
Main Authors: Pinto Rosamaria, Petriella Daniela, Lacalamita Rosanna, Montrone Michele, Catino Annamaria, Pizzutilo Pamela, Botticella Maria Antonietta, Zito Francesco Alfredo, Del Bene Gabriella, Zonno Antonia, Tommasi Stefania, De Summa Simona
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
LUAD
immunotherapy
tumor microenvironment
B cells
<i>KRAS</i>
Online Access:https://www.mdpi.com/2072-6694/11/8/1145

Internet

https://www.mdpi.com/2072-6694/11/8/1145

Similar Items